{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:45:07Z","timestamp":1787013907312,"version":"build-2736575974"},"reference-count":103,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":691,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disord"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1111\/bdi.12130","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T22:09:32Z","timestamp":1381529372000},"page":"813-823","source":"Crossref","is-referenced-by-count":11,"title":["Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins"],"prefix":"10.1111","volume":"15","author":[{"given":"Chittaranjan","family":"Andrade","sequence":"first","affiliation":[{"name":"Department of Psychopharmacology; National Institute of Mental Health and Neurosciences; Bangalore India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,10,10]]},"reference":[{"key":"10.1111\/bdi.12130-BIB0001|bdi12130-cit-0001","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"},{"key":"10.1111\/bdi.12130-BIB0002|bdi12130-cit-0002","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1007\/BF03327467","article-title":"Prevalence of overweight and obesity in Thai population: results of the National Thai Food Consumption Survey","volume":"16","author":"Jitnarin","year":"2011","journal-title":"Eat Weight Disord"},{"issue":"Suppl. 18","key":"10.1111\/bdi.12130-BIB0003|bdi12130-cit-0003","first-page":"13","article-title":"Schizophrenia and obesity: impact of antipsychotic medications","volume":"65","author":"Wirshing","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0004|bdi12130-cit-0004","first-page":"131","article-title":"Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions","volume":"23","author":"Megna","year":"2011","journal-title":"Ann Clin Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0005|bdi12130-cit-0005","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s11920-012-0313-8","article-title":"Obesity in bipolar disorder: an overview","volume":"14","author":"McElroy","year":"2012","journal-title":"Curr Psychiatry Rep"},{"key":"10.1111\/bdi.12130-BIB0006|bdi12130-cit-0006","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fpsyt.2012.00062","article-title":"Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs","volume":"3","author":"Gohlke","year":"2012","journal-title":"Front Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0007|bdi12130-cit-0007","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3810\/pgm.2012.07.2577","article-title":"Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians","volume":"124","author":"Hasnain","year":"2012","journal-title":"Postgrad Med"},{"key":"10.1111\/bdi.12130-BIB0008|bdi12130-cit-0008","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4088\/JCP.09r05346blu","article-title":"Antidepressants and body weight: a comprehensive review and meta-analysis","volume":"71","author":"Serretti","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0009|bdi12130-cit-0009","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1176\/appi.ajp.160.3.533","article-title":"Pregabalin in generalized anxiety disorder: a placebo-controlled trial","volume":"160","author":"Pande","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0010|bdi12130-cit-0010","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archpsyc.62.9.1022","article-title":"Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam","volume":"62","author":"Rickels","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0011|bdi12130-cit-0011","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2008.01204.x","article-title":"Weight gain in bipolar disorder: pharmacological treatment as a contributing factor","volume":"118","author":"Torrent","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"10.1111\/bdi.12130-BIB0012|bdi12130-cit-0012","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders - a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1111\/bdi.12130-BIB0013|bdi12130-cit-0013","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jad.2010.04.012","article-title":"Bipolar disorder and metabolic syndrome: an international perspective","volume":"126","author":"McIntyre","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1111\/bdi.12130-BIB0014|bdi12130-cit-0014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1111\/bdi.12130-BIB0015|bdi12130-cit-0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/10673220902899722","article-title":"Reproductive and metabolic abnormalities associated with bipolar disorder and its treatment","volume":"17","author":"Kenna","year":"2009","journal-title":"Harv Rev Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0016|bdi12130-cit-0016","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jad.2010.08.016","article-title":"Binge eating disorder and menstrual cycle in unmedicated women with bipolar disorder","volume":"129","author":"Schoofs","year":"2011","journal-title":"J Affect Disord"},{"key":"10.1111\/bdi.12130-BIB0017|bdi12130-cit-0017","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/schbul\/sbs082","article-title":"Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr Bull"},{"key":"10.1111\/bdi.12130-BIB0018|bdi12130-cit-0018","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/0091270010368678","article-title":"Effect of antipsychotic medications on glucose and lipid levels","volume":"51","author":"Chaggar","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/bdi.12130-BIB0019|bdi12130-cit-0019","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"Hert","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1111\/bdi.12130-BIB0020|bdi12130-cit-0020","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0021|bdi12130-cit-0021","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2011.06.008","article-title":"Life expectancy among persons with schizophrenia or bipolar affective disorder","volume":"131","author":"Laursen","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1111\/bdi.12130-BIB0022|bdi12130-cit-0022","doi-asserted-by":"crossref","first-page":"e4933","DOI":"10.1136\/bmj.e4933","article-title":"Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies","volume":"345","author":"Russ","year":"2012","journal-title":"BMJ"},{"key":"10.1111\/bdi.12130-BIB0023|bdi12130-cit-0023","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1177\/070674371005501202","article-title":"The epidemiology of excess mortality in people with mental illness","volume":"55","author":"Lawrence","year":"2010","journal-title":"Can J Psychiatry"},{"issue":"Suppl. 4","key":"10.1111\/bdi.12130-BIB0024|bdi12130-cit-0024","first-page":"4","article-title":"Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia","volume":"68","author":"Hennekens","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0025|bdi12130-cit-0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.bp.109.067512","article-title":"Twenty-five year mortality of a community cohort with schizophrenia","volume":"196","author":"Brown","year":"2010","journal-title":"Br J Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0026|bdi12130-cit-0026","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1017\/S0033291712000396","article-title":"Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia","volume":"42","author":"Lahti","year":"2012","journal-title":"Psychol Med"},{"key":"10.1111\/bdi.12130-BIB0027|bdi12130-cit-0027","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1399-5618.2009.00735.x","article-title":"Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States","volume":"11","author":"Goldstein","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1111\/bdi.12130-BIB0028|bdi12130-cit-0028","first-page":"40","article-title":"Cardiovascular morbidity and mortality in bipolar disorder","volume":"23","author":"Weiner","year":"2011","journal-title":"Ann Clin Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0029|bdi12130-cit-0029","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4088\/JCP.12ac08227","article-title":"Cardiovascular disease and bipolar disorder: risk and clinical implications","volume":"73","author":"Swartz","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0030|bdi12130-cit-0030","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4088\/JCP.v66n0905","article-title":"Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study","volume":"66","author":"Henderson","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0031|bdi12130-cit-0031","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/01.nmd.0000221177.51089.7d","article-title":"Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness","volume":"194","author":"Kreyenbuhl","year":"2006","journal-title":"J Nerv Ment Dis"},{"issue":"Suppl. 4","key":"10.1111\/bdi.12130-BIB0032|bdi12130-cit-0032","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1359786810382056","article-title":"Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis","volume":"24","author":"Mitchell","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1111\/bdi.12130-BIB0033|bdi12130-cit-0033","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1176\/appi.ps.61.9.892","article-title":"Findings of a U.S. national cardiometabolic screening program among 10,084 psychiatric outpatients","volume":"61","author":"Correll","year":"2010","journal-title":"Psychiatr Serv"},{"key":"10.1111\/bdi.12130-BIB0034|bdi12130-cit-0034","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4103\/0253-7176.101767","article-title":"Metabolic syndrome in bipolar disorders","volume":"34","author":"Grover","year":"2012","journal-title":"Indian J Psychol Med"},{"key":"10.1111\/bdi.12130-BIB0035|bdi12130-cit-0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis","volume":"123","author":"Rummel-Kluge","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1111\/bdi.12130-BIB0036|bdi12130-cit-0036","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jpsychires.2011.02.002","article-title":"Gender-specific lipid profiles in patients with bipolar disorder","volume":"45","author":"Vemuri","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1111\/bdi.12130-BIB0037|bdi12130-cit-0037","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000322999","article-title":"Statins for secondary prevention of cardiovascular disease: the right dose","volume":"87","author":"Spector","year":"2011","journal-title":"Pharmacology"},{"key":"10.1111\/bdi.12130-BIB0038|bdi12130-cit-0038","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archinternmed.2012.2145","article-title":"Statin therapy in the prevention of recurrent cardiovascular events: a sex-based meta-analysis","volume":"172","author":"Gutierrez","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1111\/bdi.12130-BIB0039|bdi12130-cit-0039","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jacc.2011.09.067","article-title":"Meta-analysis of statin effects in women versus men","volume":"59","author":"Kostis","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/bdi.12130-BIB0040|bdi12130-cit-0040","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0828-282X(08)70179-X","article-title":"Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issues","volume":"24","author":"Moride","year":"2008","journal-title":"Can J Cardiol"},{"key":"10.1111\/bdi.12130-BIB0041|bdi12130-cit-0041","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-0031-1297968","article-title":"Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis","volume":"120","author":"Chen","year":"2012","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1111\/bdi.12130-BIB0042|bdi12130-cit-0042","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/CIRCULATIONAHA.109.906479","article-title":"Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials","volume":"121","author":"Mora","year":"2010","journal-title":"Circulation"},{"key":"10.1111\/bdi.12130-BIB0043|bdi12130-cit-0043","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archinternmed.2010.182","article-title":"Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants","volume":"170","author":"Ray","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1111\/bdi.12130-BIB0044|bdi12130-cit-0044","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"19","author":"Taylor","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/bdi.12130-BIB0045|bdi12130-cit-0045","doi-asserted-by":"crossref","first-page":"E1189","DOI":"10.1503\/cmaj.101280","article-title":"Alberta Kidney Disease Network. Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis","volume":"183","author":"Tonelli","year":"2011","journal-title":"CMAJ"},{"key":"10.1111\/bdi.12130-BIB0046|bdi12130-cit-0046","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Cholesterol Treatment Trialists' (CTT) Collaborators","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0047|bdi12130-cit-0047","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1586\/erc.09.170","article-title":"Atherosclerosis prevention and treatment in children and adolescents","volume":"8","author":"Oliveira","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1111\/bdi.12130-BIB0048|bdi12130-cit-0048","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacc.2009.12.057","article-title":"Earlier intervention in the management of hypercholesterolemia: what are we waiting for?","volume":"56","author":"Steinberg","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/bdi.12130-BIB0049|bdi12130-cit-0049","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.jacc.2010.02.044","article-title":"PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses","volume":"55","author":"Benn","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/bdi.12130-BIB0050|bdi12130-cit-0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0019-5545.44900","article-title":"The prevention and treatment of cognitive decline and dementia: an overview of recent research on experimental treatments","volume":"51","author":"Andrade","year":"2009","journal-title":"Indian J Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0051|bdi12130-cit-0051","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3233\/JAD-2010-091570","article-title":"Can statins prevent or help treat Alzheimer's disease?","volume":"20","author":"McGuinness","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1111\/bdi.12130-BIB0052|bdi12130-cit-0052","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archneurol.2011.1060","article-title":"Prospective study of statin use and risk of Parkinson disease","volume":"69","author":"Gao","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1111\/bdi.12130-BIB0053|bdi12130-cit-0053","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","volume":"77","author":"Sano","year":"2011","journal-title":"Neurology"},{"key":"10.1111\/bdi.12130-BIB0054|bdi12130-cit-0054","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archneurol.2012.1132","article-title":"Age, statin use, and the risk of incident Parkinson disease","volume":"69","author":"Andrade","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1111\/bdi.12130-BIB0055|bdi12130-cit-0055","doi-asserted-by":"crossref","first-page":"e46691","DOI":"10.1371\/journal.pone.0046691","article-title":"Statin use and risk of prostate cancer: a meta-analysis of observational studies","volume":"7","author":"Bansal","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/bdi.12130-BIB0056|bdi12130-cit-0056","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2012.10.005","article-title":"Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis","volume":"144","author":"Singh","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1111\/bdi.12130-BIB0057|bdi12130-cit-0057","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.cgh.2012.12.036","article-title":"Statins are associated with reduced risk of esophageal cancer, particularly in patients with barrett's esophagus: a systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/bdi.12130-BIB0058|bdi12130-cit-0058","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1200\/JCO.2007.10.8936","article-title":"Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients","volume":"25","author":"Bonovas","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/bdi.12130-BIB0059|bdi12130-cit-0059","doi-asserted-by":"crossref","first-page":"e48095","DOI":"10.1371\/journal.pone.0048095","article-title":"Statins and hip fracture prevention - a population based cohort study in women","volume":"7","author":"Helin-Salmivaara","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/bdi.12130-BIB0060|bdi12130-cit-0060","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/gme.0b013e3181d3e036","article-title":"Statins and bone health in postmenopausal women: a systematic review of randomized controlled trials","volume":"17","author":"Yue","year":"2010","journal-title":"Menopause"},{"key":"10.1111\/bdi.12130-BIB0061|bdi12130-cit-0061","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/MOL.0b013e32834b4994","article-title":"Statins and the risk of new-onset diabetes: a review of recent evidence","volume":"22","author":"Preiss","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1111\/bdi.12130-BIB0062|bdi12130-cit-0062","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0063|bdi12130-cit-0063","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"key":"10.1111\/bdi.12130-BIB0064|bdi12130-cit-0064","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archinternmed.2011.625","article-title":"Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative","volume":"172","author":"Culver","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1111\/bdi.12130-BIB0065|bdi12130-cit-0065","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0066|bdi12130-cit-0066","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/0003319710395560","article-title":"Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators","volume":"62","author":"Whayne","year":"2011","journal-title":"Angiology"},{"key":"10.1111\/bdi.12130-BIB0067|bdi12130-cit-0067","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-150-12-200906160-00009","article-title":"Narrative review: statin-related myopathy","volume":"150","author":"Joy","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/bdi.12130-BIB0068|bdi12130-cit-0068","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/BOR.0b013e32833f0fc7","article-title":"Statin myopathy: a review of recent progress","volume":"22","author":"Mammen","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/bdi.12130-BIB0069|bdi12130-cit-0069","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/14740338.2011.540568","article-title":"Statin-induced myopathy: a review and update","volume":"10","author":"Abd","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/bdi.12130-BIB0070|bdi12130-cit-0070","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/STROKEAHA.112.655894","article-title":"Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials","volume":"43","author":"McKinney","year":"2012","journal-title":"Stroke"},{"key":"10.1111\/bdi.12130-BIB0071|bdi12130-cit-0071","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1345\/aph.1Q620","article-title":"Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations","volume":"46","author":"Rojas-Fernandez","year":"2012","journal-title":"Ann Pharmacother"},{"key":"10.1111\/bdi.12130-BIB0072|bdi12130-cit-0072","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jacc.2012.07.007","article-title":"The controversies of statin therapy: weighing the evidence","volume":"60","author":"Jukema","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/bdi.12130-BIB0073|bdi12130-cit-0073","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10549-012-2154-x","article-title":"Statin use and risk of breast cancer: a meta-analysis of observational studies","volume":"135","author":"Undela","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/bdi.12130-BIB0074|bdi12130-cit-0074","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10552-012-9979-9","article-title":"Statin use and risk of pancreatic cancer: a meta-analysis","volume":"23","author":"Cui","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1111\/bdi.12130-BIB0075|bdi12130-cit-0075","doi-asserted-by":"crossref","first-page":"e57349","DOI":"10.1371\/journal.pone.0057349","article-title":"Statins and the risk of lung cancer: a meta-analysis","volume":"8","author":"Tan","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/bdi.12130-BIB0076|bdi12130-cit-0076","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10654-009-9396-x","article-title":"Can statin therapy reduce the risk of melanoma? A meta-analysis of randomized controlled trials","volume":"25","author":"Bonovas","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1111\/bdi.12130-BIB0077|bdi12130-cit-0077","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10552-013-0159-3","article-title":"Statin use and risk of bladder cancer: a meta-analysis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1111\/bdi.12130-BIB0078|bdi12130-cit-0078","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/archinternmed.2012.2171","article-title":"Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial","volume":"172","author":"Golomb","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1111\/bdi.12130-BIB0079|bdi12130-cit-0079","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/1753-0407.12013","article-title":"The association of statin use with peripheral neuropathy in the US population 40\u00a0years of age or older","volume":"5","author":"Tierney","year":"2013","journal-title":"J Diabetes"},{"key":"10.1111\/bdi.12130-BIB0080|bdi12130-cit-0080","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.4088\/JCP.v67n1208","article-title":"Treatment with rosuvastatin for severe dyslipidemia in patients with schizophrenia and schizoaffective disorder","volume":"67","author":"Hert","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0081|bdi12130-cit-0081","first-page":"43","article-title":"Pharmacological treatment of severe dyslipidaemia in patients with schizophrenia","volume":"22","author":"Hanssens","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1111\/bdi.12130-BIB0082|bdi12130-cit-0082","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bmj.301.6747.309","article-title":"Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials","volume":"301","author":"Muldoon","year":"1990","journal-title":"BMJ"},{"key":"10.1111\/bdi.12130-BIB0083|bdi12130-cit-0083","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/bmj.322.7277.11","article-title":"Cholesterol reduction and non-illness mortality: meta-analysis of randomised clinical trials","volume":"322","author":"Muldoon","year":"2001","journal-title":"BMJ"},{"key":"10.1111\/bdi.12130-BIB0084|bdi12130-cit-0084","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/archinte.163.16.1926","article-title":"Lipid-lowering drugs and the risk of depression and suicidal behavior","volume":"163","author":"Yang","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1111\/bdi.12130-BIB0085|bdi12130-cit-0085","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2165\/00002512-200825090-00005","article-title":"Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H(2) receptor antagonists in community-dwelling older persons: cross-sectional analysis of a population-based cohort","volume":"25","author":"Feng","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1111\/bdi.12130-BIB0086|bdi12130-cit-0086","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0735-1097(03)00785-X","article-title":"Long-term statin use and psychological well-being","volume":"42","author":"Young-Xu","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/bdi.12130-BIB0087|bdi12130-cit-0087","doi-asserted-by":"crossref","first-page":"610","DOI":"10.4088\/JCP.11m07038","article-title":"Statin use and risk of depression in patients with coronary heart disease: longitudinal data from the Heart and Soul Study","volume":"73","author":"Otte","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0088|bdi12130-cit-0088","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pnpbp.2011.12.009","article-title":"Serum lipids, metabolic syndrome and lifetime suicide attempts in patients with bipolar disorder","volume":"37","author":"D'Ambrosio","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1111\/bdi.12130-BIB0089|bdi12130-cit-0089","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/archinternmed.2010.184","article-title":"Cholesterol lowering, cardiovascular diseases, and the rosuvastatin-JUPITER controversy: a critical reappraisal","volume":"170","author":"Lorgeril","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1111\/bdi.12130-BIB0090|bdi12130-cit-0090","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(12)62021-2","article-title":"Statins for people at low risk of cardiovascular disease","volume":"380","author":"Donzelli","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0091|bdi12130-cit-0091","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0140-6736(12)62022-4","article-title":"Statins for people at low risk of cardiovascular disease","volume":"380","author":"Battaggia","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0092|bdi12130-cit-0092","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/S0140-6736(12)62023-6","article-title":"Statins for people at low risk of cardiovascular disease","volume":"380","author":"Simpson","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0093|bdi12130-cit-0093","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/S0140-6736(12)62025-X","article-title":"Statins for people at low risk of cardiovascular disease","volume":"380","author":"Mascitelli","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0094|bdi12130-cit-0094","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/S0140-6736(12)62024-8","article-title":"Statins for people at low risk of cardiovascular disease","volume":"380","author":"Ray","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0095|bdi12130-cit-0095","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(12)62026-1","article-title":"Statins for people at low risk of cardiovascular disease","volume":"380","author":"Zomer","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0096|bdi12130-cit-0096","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(12)62027-3","article-title":"Statins for people at low risk of cardiovascular disease - authors' reply","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0097|bdi12130-cit-0097","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/S0140-6736(12)62028-5","article-title":"Statins for people at low risk of cardiovascular disease","volume":"380","author":"Wald","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0098|bdi12130-cit-0098","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(12)60694-1","article-title":"Statins for all by the age of 50\u00a0years?","volume":"380","author":"Ebrahim","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/bdi.12130-BIB0099|bdi12130-cit-0099","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/heartjnl-2012-302364","article-title":"New answers to three questions on the epidemic of coronary mortality in south Asians: incidence or case fatality? Biology or environment? Will the next generation be affected?","volume":"99","author":"Zaman","year":"2013","journal-title":"Heart"},{"key":"10.1111\/bdi.12130-BIB0100|bdi12130-cit-0100","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1001\/jama.2012.425","article-title":"Statin therapy for healthy men identified as \u201cincreased risk\u201d","volume":"307","author":"Blaha","year":"2012","journal-title":"JAMA"},{"key":"10.1111\/bdi.12130-BIB0101|bdi12130-cit-0101","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/jama.2012.423","article-title":"Healthy men should not take statins","volume":"307","author":"Redberg","year":"2012","journal-title":"JAMA"},{"key":"10.1111\/bdi.12130-BIB0102|bdi12130-cit-0102","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jama.2012.8729","article-title":"Use of statins in healthy men","volume":"308","author":"Beckman","year":"2012","journal-title":"JAMA"},{"key":"10.1111\/bdi.12130-BIB0103|bdi12130-cit-0103","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jama.2012.8732","article-title":"Use of statins in healthy men: in reply","volume":"308","author":"Redberg","year":"2012","journal-title":"JAMA"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbdi.12130","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bdi.12130\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T09:55:46Z","timestamp":1625392546000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bdi.12130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,10]]},"references-count":103,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1111\/bdi.12130","relation":{},"ISSN":["1398-5647"],"issn-type":[{"value":"1398-5647","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10,10]]}}}